<qa>  What is the trial of a multi-center Phase II open label trial?This is a multi-center, Phase II, open label trial evaluating the efficacy and safety of alemtuzumab and fludarabine in the treatment of B-cell chronic lymphocytic leukemia B-CLL patients who have received at least one prior therapy. 